{
  "name": "Immune Cell Entry",
  "type": "ABSTRACT_CONCEPT",
  "id": {
    "group": 50,
    "item": 1003
  },
  "claims": [
    {
      "predicate": "PERFORMED_BY",
      "object": "immune cell",
      "temporal": {
        "valid_from": null,
        "valid_until": null,
        "event": null
      },
      "epistemic": {
        "confidence": 0.8,
        "status": "SETTLED",
        "source_type": "ACADEMIC"
      }
    },
    {
      "predicate": "REQUIRES",
      "object": "HA glycocalyx",
      "temporal": {
        "valid_from": null,
        "valid_until": null,
        "event": null
      },
      "epistemic": {
        "confidence": 0.7,
        "status": "SETTLED",
        "source_type": "ACADEMIC"
      }
    },
    {
      "predicate": "REQUIRES",
      "object": "LYVE-1",
      "temporal": {
        "valid_from": null,
        "valid_until": null,
        "event": null
      },
      "epistemic": {
        "confidence": 0.7,
        "status": "SETTLED",
        "source_type": "ACADEMIC"
      }
    },
    {
      "predicate": "REQUIRES",
      "object": "CD44",
      "temporal": {
        "valid_from": null,
        "valid_until": null,
        "event": null
      },
      "epistemic": {
        "confidence": 0.7,
        "status": "SETTLED",
        "source_type": "ACADEMIC"
      }
    }
  ],
  "surface_layer": {
    "definition": "The process by which immune cells enter a specific location, requiring the HA glycocalyx, LYVE-1, and CD44.",
    "common_uses": []
  },
  "deep_layer": {
    "mechanism": "The molecular mechanisms involve the HA glycocalyx, LYVE-1, and CD44 cooperating to facilitate the entry.",
    "origin": null
  },
  "instance_layer": {
    "examples": []
  },
  "facets": {},
  "epistemic_metadata": {
    "source": "Set Automatically",
    "citations": [
      "https://pmc.ncbi.nlm.nih.gov/articles/PMC8393520/"
    ]
  }
}